Page last updated: 2024-11-06

hydroxyproline and Pulmonary Alveolar Proteinosis

hydroxyproline has been researched along with Pulmonary Alveolar Proteinosis in 1 studies

Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.

Pulmonary Alveolar Proteinosis: A PULMONARY ALVEOLI-filling disease, characterized by dense phospholipoproteinaceous deposits in the alveoli, cough, and DYSPNEA. This disease is often related to, congenital or acquired, impaired processing of PULMONARY SURFACTANTS by alveolar macrophages, a process dependent on GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Passero, MA1
Bhattacharyya, SN1
Sahu, S1
Lynn, WS1

Other Studies

1 other study available for hydroxyproline and Pulmonary Alveolar Proteinosis

ArticleYear
Crosslinking and carbohydrate studies on the hydroxylated glycopeptides which accumulate in alveoli and lamellar bodies.
    Chest, 1975, Volume: 67, Issue:2 Suppl

    Topics: Animals; Collagen; Glycine; Glycopeptides; Humans; Hydrogen-Ion Concentration; Hydrolysis; Hydroxyla

1975